AbCellera Biologics announced the appointment of Victor Sandor, M.D.C.M., to its Board of Directors as a new independent director, effective June 1, 2026. Dr. Sandor is a distinguished medical oncologist with extensive experience in clinical development and securing drug approvals at several major biopharmaceutical companies.
Key Details
- Appointment: Dr. Victor Sandor was appointed as an independent director to the Board, effective June 1, 2026.
- Experience: Dr. Sandor previously served as Chief Medical Officer at Array BioPharma, where he helped secure approvals for Braftovi® and Mektovi®, and as SVP for Global Clinical Development at Incyte, where he was critical in the approval of Jakafi®.
- Terms: He will serve until the company's next annual shareholder meeting and will participate in the standard Non-Employee Director Compensation Policy. He has not been appointed to any Board committees at this time.